IGF1R overexpression is been associated with a number of hematological neoplasias and solid tumors including breast cancer yet been implemented yet the molecular mechanism by which it contributes to carcinogenic developments is clearly not known as well as no universal scoring system has yet been implemented. Here, IGF1R is linked to breast cancer.